Vital signs of identity [biometrics] B Miller IEEE spectrum 31 (2), 22-30, 1994 | 639 | 1994 |
Ceftolozane/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial … J Solomkin, E Hershberger, B Miller, M Popejoy, I Friedland, ... Clinical Infectious Diseases 60 (10), 1462-1471, 2015 | 429 | 2015 |
States, Nations, and the Great Powers B Miller (No Title), 2007 | 360 | 2007 |
The role of retinal pigment epithelium in the involution of subretinal neovascularization. H Miller, B Miller, SJ Ryan Investigative ophthalmology & visual science 27 (11), 1644-1652, 1986 | 309 | 1986 |
A clinical prediction rule to identify febrile infants 60 days and younger at low risk for serious bacterial infections N Kuppermann, PS Dayan, DA Levine, M Vitale, L Tzimenatos, MG Tunik, ... JAMA pediatrics 173 (4), 342-351, 2019 | 288 | 2019 |
Multistate Outbreak of Salmonella Infections Associated with Peanut Butter and Peanut Butter--Containing Products--United States, 2008-2009. C Medus, S Meyer, K Smith, S Jawahir, B Miller, K Vige, M Forstner, ... MMWR: Morbidity & Mortality Weekly Report 58 (4), 2009 | 259 | 2009 |
The concept of security: Should it be Redefined? B Miller Israel's National Security towards the 21st Century, 13-42, 2014 | 222 | 2014 |
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 187 | 2018 |
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials E Liu, ME Schmidt, R Margolin, R Sperling, R Koeppe, NS Mason, ... Neurology 85 (8), 692-700, 2015 | 168 | 2015 |
When Opponents Cooperate: Great Power Conflict and Collaboration in World Politics B Miller University of Michigan Press, 2002 | 159 | 2002 |
Pathogenesis of laser-induced choroidal subretinal neovascularization. H Miller, B Miller, T Ishibashi, SJ Ryan Investigative ophthalmology & visual science 31 (5), 899-908, 1990 | 146 | 1990 |
Pharmacokinetics and safety of intravenous ceftolozane-tazobactam in healthy adult subjects following single and multiple ascending doses B Miller, E Hershberger, D Benziger, MM Trinh, I Friedland Antimicrobial agents and chemotherapy 56 (6), 3086-3091, 2012 | 135 | 2012 |
When and how regions become peaceful: potential theoretical pathways to peace B Miller International Studies Review 7 (2), 229-267, 2005 | 132 | 2005 |
Explaining changes in US grand strategy: 9/11, the rise of offensive liberalism, and the war in Iraq B Miller Security Studies 19 (1), 26-65, 2010 | 130 | 2010 |
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a … MW Popejoy, DL Paterson, D Cloutier, JA Huntington, B Miller, CA Bliss, ... Journal of Antimicrobial Chemotherapy 72 (1), 268-272, 2016 | 122 | 2016 |
Experiment in industrial democracy: A study of the John Lewis partnership AD Flanders, R Pomeranz, J Woodward (No Title), 1968 | 119 | 1968 |
Retinal wound healing: cellular activity at the vitreoretinal interface B Miller, H Miller, R Patterson, SJ Ryan Archives of Ophthalmology 104 (2), 281-285, 1986 | 117 | 1986 |
Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients … C Lucasti, E Hershberger, B Miller, S Yankelev, J Steenbergen, ... Antimicrobial agents and chemotherapy 58 (9), 5350-5357, 2014 | 116 | 2014 |
Syndromic surveillance for influenzalike illness in ambulatory care setting B Miller, H Kassenborg, W Dunsmuir, J Griffith, M Hadidi, JD Nordin, ... Emerging Infectious Diseases 10 (10), 1806, 2004 | 110 | 2004 |
The Great powers and regional conflicts: Eastern Europe and the Balkans from the post-napoleonic era to the post—cold war era B Miller, K Kagan International Studies Quarterly 41 (1), 51-85, 1997 | 102 | 1997 |